NCT06925568

Brief Summary

This study aims to understand how patients with acute chest pain are evaluated, treated, and cared for in emergency departments (EDs) at regional hospitals in Tanzania. Chest pain can be caused by many conditions, some of which are life-threatening, like heart attacks (acute coronary syndrome, or ACS). In Tanzania and other low-resource settings, delays in diagnosis and treatment can lead to poor outcomes. This study will document current practices, identify challenges, and link these findings to patient outcomes (e.g., survival, complications) to improve care for future patients. \- Participants: Adults (18 years or older) who come to the ED with chest pain or suspected acute coronary syndrome (heart problem) at the regional referral hospitals in Dar es Salaam, Tanzania. Three regional referral hospitals and one specialized cardiac hospital (Jakaya Kikwete Cardiac Institute) will be involved in this study. Research assistants will collect data during routine care. During the study, i. Enrollment will take place over 12 months; 317 patients with chest pain will be invited to participate. ii. Researchers will record:

  • How quickly patients receive initial diagnostic tests (e.g., ECG, blood tests for heart damage).
  • Treatments given (e.g., medications, procedures to restore blood flow to the heart).
  • Patient outcomes over 30 days (e.g., survival, readmission to the hospital, complications like another heart attack or stroke). iii. Follow-up: Patients will be contacted by phone 30 days after their ED visit to check their health status. This study is important because-: Chest pain is a common reason for ED visits, but in Tanzania, many patients face delays in diagnosis or lack access to lifesaving treatments. This study will identify gaps in care to help hospitals improve emergency services. Understanding the challenges in chest pain care can empower families to advocate for timely treatment for their loved ones. For Healthcare Providers: The findings will guide hospitals in adopting better protocols (e.g., faster ECGs, improved use of medications) and allocating resources effectively. For Policymakers: Results can inform national strategies to reduce deaths from heart disease in Tanzania. During the study, participants should know that there will be no changes to care; patients will receive the same care they would normally get. The study only observes and records what happens. Personal information will be kept confidential, and data will be anonymized (no names or identifiers used). Participation is voluntary, and patients can choose to join or refuse without affecting their care. Key Questions the Study Will Answer
  • How quickly do patients with chest pain get critical tests (like ECGs) and treatments in Tanzanian hospitals?
  • What are the most common barriers to timely care (e.g., lack of equipment, training gaps)?
  • What percentage of patients survive 30 days after a chest pain episode, and what factors influence their outcomes? Potential Benefits
  • Improved Care: Findings may lead to better hospital protocols.
  • Resource Allocation: Highlight where hospitals need more tools (e.g., ECG machines) or medications
  • Global Impact: Lessons from Tanzania can help other low-resource countries improve emergency heart care. Ethical Considerations
  • Approval: The study has been reviewed and approved by ethics committees to ensure patient safety and rights.
  • Informed Consent: Participants (or their families, if critically ill) will be asked for permission before joining. How will results be shared-: Findings will be published in medical journals and shared with Tanzanian hospitals, health officials, and global organizations to drive improvements in emergency care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
317

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 13, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

April 13, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

April 7, 2025

Last Update Submit

April 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • all-cause mortality

    30days

Secondary Outcomes (4)

  • Management provided to ACS patients

    30days

  • Time intervals taken from the initial hospital presentation to the initial management.

    30days

  • The occurrence of a major adverse cardiovascular event (MACE) within 30 days after the patient's initial presentation to the emergency department.

    30days

  • ED readmission within 30 days after the initial visit.

    30days

Study Arms (1)

Patients above 18yrs presenting with acute chest pain or Suspected Acute Coronary Syndrome (ACS).

Other: No Intervention: Observational Cohort

Interventions

This is an observational study, so there is no direct intervention. However, the study involves documenting and analyzing the existing management strategies, including * use of diagnostic tools ECG, troponin tests, etc * Administration of medications such as antiplates and anticoagulants. * Reperfusion therapies -thrombolysis, PCI

Patients above 18yrs presenting with acute chest pain or Suspected Acute Coronary Syndrome (ACS).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Nontraumatic patients with acute chest pain or suspected acute coronary syndrome (ACS) presenting to the ED at regional referral hospitals.

You may qualify if:

  • Patients aged eighteen years and above who present at the ED with nontraumatic acute chest pain or suspected acute coronary syndrome and who provided informed consent.

You may not qualify if:

  • Patients with known lung cancer.
  • Lost to follow-up
  • The patient arrives in cardiac arrest.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 7, 2025

First Posted

April 13, 2025

Study Start

May 1, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

April 13, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share